331
Participants
Start Date
September 30, 2008
Primary Completion Date
March 31, 2012
Study Completion Date
July 31, 2012
rhGAD65
Diamyd (rhGAD65) 20 µg injected subcutaneously at days 1, 30, 90 and 270.
rhGAD65
Diamyd (rhGAD65) 20 µg injected subcutaneously at days 1 and 30, followed by placebo injections at days 90 and 270.
Placebo
Placebo injected subcutaneously at days 1, 30, 90 and 270.
Naomi Berrie Diabetes Center of Columbia University, New York
Winthrop University Hospital, Mineola
SUNY Institute for Human Performance, Syracuse
University of Rochester, Rochester
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Christina Care Research institute, Newark
University of Maryland Medical Center, Baltimore
Virginia Commonwealth University, Richmond
Atlanta Diabetes Associates, Atlanta
Nemours Children's Clinic, Jacksonville
University of Florida, Gainsville
Miami Children's Hospital Research Institute, Miami
University of South Florida, Tampa
LeBonheur Children's Medical Center, Memphis
University of Louisville Research Foundation, Louisville
University of Kentucky College of Medicine, Lexington
Children's Hospital Medical Center of Akron, Akron
University of Michigan Health System, Ann Arbor
Alzohaili Medical Consultants, Dearborn
University of Iowa Hospitals and Clinicals, Iowa City
Regional Medical Clinic - Endocrinology, Rapid City
St. Louis Children's Hospital, St Louis
The Children's Mercy Hospital, Kansas City
Mid America Diabetes Associates, Wichita
Creighton Diabetes Center, Omaha
Children's Hospital, New Orleans
Arkansas Children's Hospital Research Institute, Little Rock
Alex Endocrine Associates, Rogers
University of Oklahoma, Schustermann Center Clinic, Tulsa
Cook Children's Medical Center, Fort Worth
CHRISTUS Santa Rosa Children's Hospital, San Antonio
Barbara Davis Center for Childhood Diabetes, Aurora
Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls
University of Arizona, Tucson
Kathryn Eckert, Reno
Rady Children's Hospital, San Diego
Children's Hospital Orange County, Orange
Stanford University Medical Center, Stanford
Benaroya Research Institute, Seattle
Tufts Medical Center, Boston
UMass Memorial Medical Center, Worcester
Hackensack University Medical Center, Hackensack
Morristown Memorial Hospital, Morristown
Lead Sponsor
Diamyd Therapeutics AB
INDUSTRY